Remove Collaboration Remove Contract research organization Remove Utilities Related Topics
article thumbnail

Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?

Frost & Sullivan

Growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) leading industry growth. Top 10 pharma companies contribute only 4-5% to R&D pipeline; top 25 contribute less than 10%.

article thumbnail

How does your company’s benchmarking performance stack up against the leading precision health companies in the ecosystem?

Frost & Sullivan

Utilize this distinctive competitive benchmarking tool to elevate your future growth potential significantly. Let us coach you on your transformational journey, while we actively support you in fostering collaborative initiatives within your industry’s ecosystem.